Clinical trial
Inflammation and Biopsy-site-marker in Breast Cancer (MOSAIC)
NCT07833566 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inflammation and Biopsy-site-marker in Breast Cancer (MOSAIC)
- Lead sponsor
- University of Oklahoma
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 9, 2026
- Completion date
- July 31, 2030
- Enrollment
- 140 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer